emka & SCIREQ recently hosted a free virtual panel discussion on September 23rd at 11:00am EST. Experts at the forefront of inhalation toxicology research discussed Pre-Clinical Models of Smoke Exposure and provide deeper analysis of pre-clinical smoke modelling and the cardiopulmonary outcomes.

Smoking continues to be one of the leading causes of death in the world. With the rise of popularity of Electronic Nicotine Delivery Systems (ENDS) devices, further scientific research is needed to: 

• Understand smoke-induced pathophysiological mechanisms 
• Develop novel therapeutic agents to treat patients
• Guide the decision-making process for the use of ENDS devices

In addition, the legalization of Cannabis in Canada and various states across the US has created more funding opportunities to understand the pulmonary effects of inhaled cannabis better and improve our understanding of the endocannabinoid system and the potential therapeutic applications.

Learn About the Panelists

DR. ALEX CARLL – UNIVERSITY OF LOUISVILLE

Dr. Carll's research focuses on the effects of air pollutants on the heart, and how it impairs cardiac conduction, compromises hemodynamics, and whether such effects occur through the autonomic nervous system. Learn more about Dr. Carll here.

DR. ALEXANDRA NOËL –  LOUISIANA STATE UNIVERSITY

Dr. Noël's lab studies the mechanisms that underlie the developmental origins of health and disease, with respect to respiratory effects caused by distinct emerging inhaled environmental pollutants. Learn more about her lab here.

DR. CAROLYN BAGLOLE –MCGILL UNIVERSITY

Dr. Baglole's lab focuses on how chronic lung diseases such as COPD are associated with environmental exposures, particularly cigarette smoke. Learn more about her work here.

DR. LAURA CROTTY ALEXANDER – UC SAN DIEGO 

Dr. Crotty Alexander's research interests are primarily focused on E-cigarettes. She studies the impact of E-cigarettes on airway inflammation and innate immune function. Check out some of her publications here. 

Agenda